Jin‐Hyuk Choi

PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer

Yoon‐Koo Kang, Jeong Hwan Yook, Young-Kyu Park et al. · Journal of Clinical Oncology · 2021 · 332 citations · Full text

Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer

Joon Oh Park, Sang‐We Kim, Jin Seok Ahn et al. · Journal of Clinical Oncology · 2007 · 181 citations · Full text

Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma

Young‐Taek Oh, Chulho Kim, Jin‐Hyuk Choi et al. · Radiotherapy and Oncology · 2004 · 74 citations

Neuro-oncology, Radiation Therapy, Nasopharyngeal Cancer +9

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in advanced non-small cell lung cancer patients treated with platinum-based doublet chemotherapy

Hyun Woo Lee, Yong-Won Choi, Jae Ho Han et al. · Lung Cancer · 2009 · 57 citations

Surgical Oncology, Platinum-based Doublet Chemotherapy, Medicine +9

EGFR Exon 19 Deletion is Associated With Favorable Overall Survival After First-line Gefitinib Therapy in Advanced Non–Small Cell Lung Cancer Patients

Yong Won Choi, So Yeon Jeon, Geum Sook Jeong et al. · American Journal of Clinical Oncology · 2016 · 51 citations